Skip to content

Congress SMID Growth ETF

CSMDNYSE ArcaC

$34.33−0.12 (−0.33%)

As of Oct 13, 2026, 3:59 PM

Intraday session: down, 77 prints from 34.45 to 34.33. Range 34.05 to 34.51. Use the arrow keys to read each point.34.1034.2034.5010 AM12 PM2 PM4 PM
Expense ratio
0.68%
Fund size
$482M
1Y total return
+6.4%
Yield · Last 12 months
0.00%
Holdings
47
Avg volume · 30D
0M sh
NAV per share
$34.64
52W range
low $29.53high $37.04
Launched

The ETF.net CSMD Grade

Based on 5 of 6 pillars

C

Score 42 out of 100

Rank
25 of 41
Six-pillar profile for CSMD. Scores out of 100: Cost 43, Risk 30, Mission not scored, Tradability 56, Holdings 34, Durability 59. Strongest: Durability (59). Weakest: Risk (30). Based on 5 of 6 pillars.

Score 42 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C43 out of 100
    Rank 24 of 41
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    D30 out of 100
    Rank 30 of 38
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B56 out of 100
    Rank 17 of 41
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D34 out of 100
    Rank 36 of 41
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B59 out of 100
    Rank 18 of 41

Our read on CSMD

ETF.net Research

CA stock picker in a corner of the market dominated by rules-based funds. Congress hunts growth across the small-and-mid-cap band instead of one style box, and charges above the category median for a human team's judgment.

Stated mandate

The fund seeks long-term capital appreciation.

Why people hold it

  1. 01Simple mandate, wide net: long-term capital appreciation, with a SMID remit that lets the managers own smaller and mid-sized names instead of being boxed into one size band.
  2. 02Trading is the smoothest part of the package. It changes hands often enough that ordinary retail-sized orders aren't wrestling a thin market.
  3. 03Not a just-launched experiment: live since 2023, with real assets behind it rather than a rounding error, run by Congress Asset Management.

Worth knowing

  1. 01Cost is the trade-off. At 0.68% a year it sits above the typical fund in its category, while systematic rivals like AVUV run 0.25% and DUHP 0.20%.
  2. 02No index rulebook to check it against. This is a discretionary portfolio in a slice of the market that swings harder than large caps.
  3. 03Built for growth, not a paycheck: the stated goal is capital appreciation, and the fund has not been running a regular distribution.

CSMD Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
47
Top-10 weight
32%
Largest holding
RBRK4.4%

Sectors

  • Health Care26.2%
  • Technology25.5%
  • Industrials20.0%
  • Consumer Staples6.7%
  • Financials6.4%
  • Consumer Discretionary5.9%
  • Energy4.1%
  • Communication1.9%
  • Materials1.7%
  • Real Estate1.6%

Geography

  • United States93.90%
  • United Kingdom2.72%
  • Ireland2.10%
  • Cayman Islands1.28%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001RBRKRubrik Inc4.36%167,922$21M148
002HALOHalozyme Therapeutics Inc3.74%162,885$18M208
003RGENRepligen Corp3.34%92,384$16M158
004VMIValmont Industries Inc3.27%33,688$16M172
005RMBSRambus Inc3.12%139,687$15M173
006UFPTUFP Technologies Inc2.90%48,257$14M103
007MEDPMedpace Holdings Inc2.87%22,546$14M204
008ENTGEntegris Inc2.78%80,730$13M216
009IOTSamsara Inc2.77%321,417$13M178
010BJBJ's Wholesale Club Holdings Inc2.75%134,135$13M152
011AFRMAffirm Holdings Inc2.72%162,424$13M169
012NVTnVent Electric PLC2.72%78,107$13M251
013LGNDLigand Pharmaceuticals Inc2.69%42,880$13M131
014ELFelf Beauty Inc2.60%114,831$13M122
015AMRXAmneal Pharmaceuticals Inc2.53%611,388$12M131

Showing 1–15 of 47 holdings

CSMD Performance

Launched Aug 21, 2023

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.
CSMD$10,636
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. CSMD $10,636. SPY $12,044. Use the arrow keys to read each point.$9,195$10,733$12,271Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for CSMD. Periods over one year show the average yearly return.
PeriodCSMD
Year to date+8.9%
1 month+3.1%
3 months−2.2%
1 year+6.4%
3 yearsper year+12.8%
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for CSMD
YearReturn barCSMD
2026 YTD+8.9%
2025+5.7%
2024+12.3%
2023+6.6%

Since listing, Aug 21, 2023

CSMD in the news

Filtered to CSMD · US Active Small-Cap

CSMD Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
0.00%Last 12 months
Payout per share
NoneLast 12 months

No distributions in the last 12 months.

Distribution history

Payments through 2024

One bar per payment. 2 payments from 2023 to 2024. Dec 11, 2023 $0.0057; Dec 12, 2024 $0.00017. Use the arrow keys to read each point.20232024
Ex-datePay dateAmount per share
Dec 12, 2024Dec 13, 2024$0.00017
Dec 11, 2023Dec 13, 2023$0.0057

CSMD Risk

How much the fund’s monthly returns vary, scaled to a year.
18.2%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.46
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−22.6%
37 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.16
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

CSMD Cost

Expense ratio0.68%
  • The middle half of US Active Small-Cap funds
  • Median 0.55%

22 of the 39 US Active Small-Cap funds charge less.

CSMD costs $68.00 a year on $10,000. The median US Active Small-Cap fund costs $55.00.

Other funds in US Active Small-Cap